Ginkgo Bioworks Inc.

NYSE: DNA · Real-Time Price · USD
7.92
0.25 (3.26%)
At close: May 16, 2025, 3:59 PM
7.94
0.32%
After-hours: May 16, 2025, 08:00 PM EDT

Ginkgo Bioworks Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Service Revenue 53.07M 78.97M 298.58M 177.81M
Service Revenue Growth -32.80% -73.55% +67.93% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Selling, General, and Administrative Revenue 49.04M 57.3M 52.29M 66.28M 51.02M 65.56M 82.03M 102.34M 111.43M 121.42M 435.18M 438.43M 434.77M 781.63M 28.96M 34.44M 17.93M 12.91M 9.88M 8.95M 6.57M
Selling, General, and Administrative Revenue Growth -14.41% +9.57% -21.11% +29.91% -22.18% -20.08% -19.85% -8.16% -8.23% -72.10% -0.74% +0.84% -44.38% +2599.08% -15.91% +92.11% +38.83% +30.75% +10.36% +36.25% n/a
Research and Development Revenue 70.92M 76.38M 77.01M 134.22M 123.59M 107.7M 156.66M 144.28M 162.64M 181.16M 259.58M 289.19M 322.72M 985.02M 53.02M 52.03M 59.59M 61.19M 36.07M 32.27M 30.24M
Research and Development Revenue Growth -7.14% -0.82% -42.63% +8.60% +14.75% -31.25% +8.58% -11.29% -10.22% -30.21% -10.24% -10.39% -67.24% +1757.80% +1.90% -12.68% -2.62% +69.65% +11.78% +6.73% n/a